Gemmer Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-159
| Closed | -$41K | – | 1113 |
|
|
2022
Q1 | $41K | Hold |
159
| – | – | 0.01% | 314 |
|
|
2021
Q4 | $35K | Hold |
159
| – | – | ﹤0.01% | 354 |
|
|
2021
Q3 | $29K | Sell |
159
-14
| -8% | -$2.73K | ﹤0.01% | 380 |
|
|
2021
Q2 | $35K | Buy |
173
+3
| +2% | +$628 | ﹤0.01% | 356 |
|
|
2021
Q1 | $37K | Buy |
170
+15
| +10% | +$3.29K | 0.01% | 317 |
|
|
2020
Q4 | $37K | Sell |
155
-7
| -4% | -$1.61K | 0.01% | 289 |
|
|
2020
Q3 | $44K | Hold |
162
| – | – | 0.01% | 230 |
|
|
2020
Q2 | $47K | Buy |
162
+7
| +5% | +$1.9K | 0.01% | 208 |
|
|
2020
Q1 | $37K | Hold |
155
| – | – | 0.01% | 216 |
|
|
2019
Q4 | $34K | Sell |
155
-23
| -13% | -$4.66K | 0.01% | 263 |
|
|
2019
Q3 | $30K | Buy |
178
+4
| +2% | +$708 | 0.01% | 280 |
|
|
2019
Q2 | $32K | Sell |
174
-74
| -30% | -$12.9K | 0.01% | 265 |
|
|
2019
Q1 | $46K | Sell |
248
-15
| -6% | -$2.77K | 0.01% | 205 |
|
|
2018
Q4 | $44K | Hold |
263
| – | – | 0.01% | 195 |
|
|
2018
Q3 | $51K | Sell |
263
-80
| -23% | -$14.2K | 0.02% | 178 |
|
|
2018
Q2 | $58K | Hold |
343
| – | – | 0.02% | 161 |
|
|
2018
Q1 | $56K | Hold |
343
| – | – | 0.02% | 169 |
|
|
2017
Q4 | $51K | Hold |
343
| – | – | 0.02% | 185 |
|
|
2017
Q3 | $52K | Hold |
343
| – | – | 0.02% | 174 |
|
|
2017
Q2 | $44K | Hold |
343
| – | – | 0.02% | 196 |
|
|
2017
Q1 | $38K | Hold |
343
| – | – | 0.02% | 203 |
|
|
2016
Q4 | $25K | Buy |
343
+2
| +0.6% | +$163 | 0.01% | 271 |
|
|
2016
Q3 | $30K | Hold |
341
| – | – | 0.02% | 238 |
|
|
2016
Q2 | $29K | Hold |
341
| – | – | 0.02% | 225 |
|
|
2016
Q1 | $27K | Hold |
341
| – | – | 0.02% | 239 |
|
|
2015
Q4 | $43K | Sell |
341
-102
| -23% | -$12.3K | 0.03% | 174 |
|
|
2015
Q3 | $46K | Hold |
443
| – | – | 0.03% | 189 |
|
|
2015
Q2 | $55K | Hold |
443
| – | – | 0.03% | 166 |
|
|
2015
Q1 | $52K | Hold |
443
| – | – | 0.03% | 175 |
|
|
2014
Q4 | $53K | Hold |
443
| – | – | 0.04% | 168 |
|
|
2014
Q3 | $50K | Hold |
443
| – | – | 0.04% | 172 |
|
|
2014
Q2 | $42K | Hold |
443
| – | – | 0.03% | 187 |
|
|
2014
Q1 | $31K | Buy |
+443
| New | +$35.1K | 0.02% | 218 |
|
Other funds holding VRTX
Gemmer Asset Management's VRTX Position: Q2 2022 in Review
Gemmer Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q2 2022, closing a stake of 159 shares — an estimated $41K sold.
Gemmer Asset Management first reported a position in VRTX in Q1 2014 and held it in 33 quarters. The position peaked at $58K in Q2 2018. 1,108 funds tracked by Wall St. Rank hold VRTX as of Q2 2022.
- Gemmer Asset Management reported no remaining Vertex Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
- Gemmer Asset Management sold 159 Vertex Pharmaceuticals shares in Q2 2022, an estimated $41K.
- Gemmer Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2014 and held it in 33 quarters.
- Gemmer Asset Management's Vertex Pharmaceuticals position peaked at $58K in Q2 2018.
- 1,108 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2022.
Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.